Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication
Kinoshita, Toshihiko, Takekita, Yoshiteru, Hiraoka, Shuichi, Tamura, Fumihiro, Iwama, Yasuhiro
Published in Neuropsychopharmacology reports (01.09.2023)
Published in Neuropsychopharmacology reports (01.09.2023)
Get full text
Journal Article